Wintac Ltd
Wintac is engaged in Business of Formulation Sales, Manufacturing Charges and Formulation Development.
- Market Cap ₹ 342 Cr.
- Current Price ₹ 342
- High / Low ₹ /
- Stock P/E 194
- Book Value ₹ -7.36
- Dividend Yield 0.00 %
- ROCE -5.76 %
- ROE %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is expected to give good quarter
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
15 | 21 | 27 | 24 | 21 | 30 | 29 | 18 | 33 | 44 | 72 | 85 | 125 | |
15 | 17 | 21 | 25 | 24 | 32 | 32 | 33 | 41 | 50 | 68 | 83 | 114 | |
Operating Profit | 0 | 4 | 5 | -0 | -3 | -1 | -3 | -15 | -8 | -6 | 4 | 2 | 11 |
OPM % | 1% | 18% | 20% | -1% | -15% | -5% | -10% | -85% | -26% | -14% | 5% | 2% | 9% |
0 | 1 | 0 | 0 | -10 | -3 | -1 | 4 | 3 | 1 | 2 | 3 | 3 | |
Interest | 1 | 2 | 3 | 3 | 3 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 3 |
Depreciation | 1 | 1 | 2 | 2 | 2 | 2 | 4 | 4 | 4 | 4 | 4 | 7 | 9 |
Profit before tax | -2 | 1 | 1 | -5 | -18 | -6 | -8 | -16 | -10 | -10 | 0 | -4 | 2 |
Tax % | 1% | 0% | -3% | 6% | -3% | 8% | -20% | -7% | -13% | 1% | 48% | -15% | |
-2 | 1 | 1 | -5 | -17 | -7 | -6 | -15 | -8 | -10 | 0 | -3 | 2 | |
EPS in Rs | -3.34 | 1.87 | 1.28 | -8.93 | -17.16 | -6.97 | -6.14 | -15.09 | -8.44 | -9.77 | 0.11 | -3.05 | 1.76 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 15% |
5 Years: | 24% |
3 Years: | 37% |
TTM: | 56% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 2% |
3 Years: | 17% |
TTM: | -73% |
Stock Price CAGR | |
---|---|
10 Years: | 5% |
5 Years: | 33% |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 6 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 11 | 12 | 16 | 14 | 32 | 25 | 19 | 4 | -4 | -14 | -14 | -18 |
16 | 17 | 23 | 21 | 6 | 1 | 0 | 10 | 8 | 7 | 66 | 28 | |
9 | 8 | 12 | 12 | 12 | 15 | 20 | 29 | 45 | 70 | 74 | 141 | |
Total Liabilities | 40 | 42 | 55 | 53 | 61 | 52 | 50 | 53 | 58 | 73 | 136 | 162 |
19 | 21 | 24 | 25 | 22 | 30 | 32 | 32 | 32 | 32 | 52 | 107 | |
CWIP | 2 | 0 | 1 | 2 | 2 | 0 | 0 | 2 | 0 | 6 | 39 | 1 |
Investments | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
18 | 20 | 30 | 26 | 36 | 22 | 18 | 19 | 26 | 35 | 45 | 54 | |
Total Assets | 40 | 42 | 55 | 53 | 61 | 52 | 50 | 53 | 58 | 73 | 136 | 162 |
Cash Flows
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 2 | 3 | 4 | -3 | -6 | 6 | -4 | 4 | 18 | -4 | 60 | |
-2 | -2 | -6 | -4 | -0 | -7 | -6 | -5 | -2 | -16 | -56 | -20 | |
-0 | 0 | 4 | -0 | 20 | -4 | -1 | 9 | -3 | -2 | 59 | -40 | |
Net Cash Flow | -0 | 0 | 1 | -0 | 17 | -17 | -0 | -0 | -0 | 1 | -0 | -0 |
Ratios
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 106 | 101 | 105 | 64 | 64 | 69 | 31 | 59 | 40 | 7 | 10 | 13 |
Inventory Days | 177 | 165 | 238 | 191 | 241 | 194 | 176 | 268 | 208 | 180 | 260 | 257 |
Days Payable | 158 | 161 | 269 | 232 | 338 | 245 | 188 | 240 | 166 | 94 | 169 | 134 |
Cash Conversion Cycle | 126 | 105 | 73 | 23 | -33 | 17 | 18 | 87 | 83 | 92 | 101 | 136 |
Working Capital Days | 211 | 197 | 35 | -23 | -9 | -10 | -137 | -370 | -300 | -413 | -208 | -405 |
ROCE % | -3% | 9% | 9% | -5% | -10% | -6% | -16% | -64% | -52% | -110% | 4% | -6% |
Documents
Announcements
-
Delisting Exit Offer
15 Dec 2020 - Capital Markets Ltd ("Manager to the Delisting Offer") has submitted to BSE a copy of Exit Offer Public Announcement for the attention of Equity Shareholders …
-
Updates on Delisting Offer
15 Dec 2020 - Capital Markets Ltd ("Manager to the Delisting Offer") has submitted to BSE a copy of Delisting Public Announcement for the attention of Equity Shareholders of …
- Reg. 34 (1) Annual Report 7 Dec 2020
- Outcome Of Board Meeting 3 Dec 2020
- Board Meeting Intimation for Board Meeting Intimation For Considering Borrowing Of Funds 30 Nov 2020
Annual reports
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse